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Background: Previous studies examining the association of albuminuria (AL) with outcomes in acute myocardial infarction (AMI) patients may be 
confounded by inaccuracies in urine protein testing at the time of AMI. We assessed the relation of AL, measured 1 month after AMI, as a risk factor 
for adverse outcomes and studied its interaction with diabetes status. 
methods: 882 patients from the 24-center TRIUMPH registry had urinary albumin creatinine ratio (UACR) measured 1 month after hospitalization 
with AMI. Patients were stratified into 4 groups based on AL (defined as UACR ≥30 μg/mg) and diabetes status. After propensity adjustment for 
differences in patient characteristics, including creatinine clearance (CrCl), we estimated 1 month to 3 years all-cause mortality. 
results: AL was present in 100/561 (17.8%) of non-diabetic and 133/321 (41.1%) of diabetic patients. Figure 1 shows the 3-year survival 
Kaplan-Meier estimates for various subgroups. Using sequential proportional hazards regression, hazard ratios for the association between AL and 
3-year mortality were 1.78 (1.08, 2.94) for the overall cohort, 1.44 (0.70, 2.96) for diabetics, and 2.20 (1.07, 4.54) for non-diabetics (p=0.86 for 
interaction between the association of AL with mortality and diabetes status).
conclusion: AL assessed 1 month after AMI is associated with long-term mortality in diabetics and non-diabetics, even after adjusting for CrCl and 
other risk factors. This could be a technique for restratifying risk in post-AMI patients.
